JAGX

Conviction 22HealthcareScan · Mon, Aug 10, 2026

JAGX$0.8331-12.31%

ResistanceSupportVol 14

Vol MA14 94.82K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Jaguar Health, Inc.PHARMACEUTICAL PREPARATIONSwww.jaguar.health ↗

Price0.8331

Change-12.31%

Gap+1.04%

Rel volume0.14×

Avg volume100.14K

Avg $ vol113.33K

SMA 201.17

SMA 502.11

SMA 2001.49

Price vs 50-60.55%

Price vs 200-44.16%

MA stackmixed

50/200 cross—

Supertrenddown · 1.32

RSI (14)25

MACD hist0.03

MACD crossbull · 3d

Stoch %K / %D1 / 5

ADX (14)41

+DI / −DI13 / 38

RSI divergence—

MACD divergenceBullish

ATR %+20.33%

ADR %13.87%

52w high6.96

52w low0.2250

From 52w high-88.03%

Above 52w low+270.27%

New 52w highNo

SqueezeOff

Bollinger width113.68%

%B0.25

Donchian pos0.29%

Donchian high2.25

Donchian low0.8290

AVWAP (52w high)2.64

vs AVWAP high-68.47%

AVWAP (52w low)2.40

vs AVWAP low-65.34%

OBV trendDown

Chaikin MF (20)-0.20

Today vs 20d0.14×

Avg vol (14d)94.82K

Avg vol (20d)100.14K

Avg $ vol (20d)113.33K

Market cap142.75M

RS 3m (vs SPY)-73.81%

RS 6m (vs SPY)+46.29%

RS line new highNo

Trend template3/8

Technical rank27.5

1 week-16.69%

1 month-63.94%

3 months-72.23%

6 months+24.34%

1 year-60.33%

YTD-16.48%

P/E-2.66

P/B6.62

P/S—

P/FCF-6.02

EPS-22.97

Div yield—

ROE-248.58%

ROA-143.12%

Debt/Eq0.50

Current0.50

EV/EBITDA-3.32

Gross margin—

Net margin—

Rev growth—

EPS growth-39.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value146.24M

Revenue883.85K

Net income-9.5M

Gross profit—

Free cash flow-23.7M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out603.13K

Employees47

ListedWed, May 13, 2015

Free float12.41M

Float %88.4%

Short interest51.69K

Days to cover1.5d

Short volume58.0%

Squeeze score20 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank27.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.06

Support0.9350

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Sep 30, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in JAGX

All disclosures →

No recent disclosed trades by Congress in JAGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JAGX

No recent insider (Form 4) filings in JAGX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JAGX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.